PlainPill

NRX-1074

Based on 2 first-hand reports. Ranked #1853 of 1,974 overall.

5
User score
Not enough data
0% positive0% mixed0% negative100% unclear

Of reports that state an outcome, 0% are positive.

Clinical research
Research pending
High-risk compound. Peptides are not approved as supplements, carry serious and sometimes irreversible risks, are banned in competitive sport and may be restricted where you live. Nothing here is a recommendation to use it.

What NRX-1074 does, according to users

Of the people who reported each effect, the share who said it got better.

No specific effects reported yet.
betterno changeworse

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

Research data for NRX-1074 is being compiled.

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

No doses stated in the reports so far.

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

Verbatim quotes, shortened only — each links to the original discussion.

“NRX-1074”
Source discussion ↗
“an orally-active molecule, NRX-1074, is in current development by the same company (Naurex Neuropharmaceuticals) though it remains in pre-clinical trials”
Source discussion ↗
Top discussions (2)

More peptides

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate